Home › Attention Deficit Hyperactivity Disorder › NCT07380412

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Who can join

Ages 18 to 55 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Aged 18-55 years
* Currently prescribed stimulant medication for ADHD
* Experiencing: sleep difficulty, irritability, anxiety, brain fog
* Stable medication dose ≥3 months
* Healthy with no uncontrolled chronic conditions
* Stable on supplements ≥3 months if applicable
* US resident
* Willing to maintain current habits

Exclusion Criteria:

* Chronic conditions (e.g. cancer, mental illness)
* Use of psychiatric medications besides stimulants
* Pregnancy, breastfeeding, thyroid, liver, kidney conditions
* Recent smokers or heavy alcohol use
* Night shift workers
* Participation in other clinical trials
* Allergies to product ingredients

About the study

This is a hybrid, two-arm, triple-blind, placebo-controlled, randomized clinical trial evaluating the efficacy of the Stasis supplement on reducing oxidative stress, cortisol levels, and side effects associated with stimulant medications used for ADHD over a three-month period in adults.

What is being tested

• Stasis Daytime and Nighttime (dietary supplement)
• Placebo (dietary supplement)

Sponsor: Outliers, Inc. · Participants: 90 · Started: Aug 12, 2025

Contact the study team

• Patrick Renner, MSc · Phone: 4242450284

Official record on ClinicalTrials.gov — NCT07380412

Locations in the U.S.

Conditions

• Attention Deficit Hyperactivity Disorder
• Parasomnias
• Mental Fatigue
• Anxiety

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.